Prestige Consumer Healthcare (PBH) Accumulated Expenses (2011 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Accumulated Expenses came in at $15.1 million in Q4 2025, down 75.25% year-on-year from $60.9 million in Q4 2024, and down 3.21% quarter-over-quarter from $15.6 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Accumulated Expenses (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Accumulated Expenses history runs 15 years deep, the most recent figure standing at $15.1 million for Q4 2025.
- On a quarterly basis, Accumulated Expenses fell 75.25% year-over-year to $15.1 million in Q4 2025; TTM through Dec 2025 was $15.1 million, a 75.25% decrease from a year earlier, with the FY2025 full-year figure at $63.5 million, up 302.58% from the prior year.
- Accumulated Expenses fell to $15.1 million in Q4 2025 per PBH's latest filing, from $15.6 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $74.1 million in Q1 2022 and bottomed at $6.3 million in Q1 2021.
- The 5-year median for Accumulated Expenses is $16.6 million (2021), against an average of $37.9 million.
- Across the five-year window, Accumulated Expenses tumbled 91.08% in 2021 and soared 1074.16% in 2022, its largest moves.
- Year by year, Accumulated Expenses stood at $15.1 million in 2021, then surged by 369.59% to $71.0 million in 2022, then tumbled by 78.59% to $15.2 million in 2023, then jumped by 300.84% to $60.9 million in 2024, then plunged by 75.25% to $15.1 million in 2025.
- Per Business Quant, the three latest PBH Accumulated Expenses figures stand at $15.1 million (Q4 2025), $15.6 million (Q3 2025), and $15.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.08 Mn |
| Sep 30, 2025 | 15.58 Mn |
| Jun 30, 2025 | 15.08 Mn |
| Mar 31, 2025 | 63.46 Mn |
| Dec 31, 2024 | 60.92 Mn |
| Sep 30, 2024 | 15.71 Mn |
| Jun 30, 2024 | 54.86 Mn |
| Mar 31, 2024 | 15.76 Mn |
| Dec 31, 2023 | 15.20 Mn |
| Sep 30, 2023 | 60.08 Mn |
| Jun 30, 2023 | 15.19 Mn |
| Mar 31, 2023 | 72.52 Mn |
| Dec 31, 2022 | 70.98 Mn |
| Sep 30, 2022 | 70.98 Mn |
| Jun 30, 2022 | 15.18 Mn |
| Mar 31, 2022 | 74.11 Mn |
| Dec 31, 2021 | 15.12 Mn |
| Sep 30, 2021 | 17.53 Mn |
| Jun 30, 2021 | 68.44 Mn |
| Mar 31, 2021 | 6.31 Mn |